CME Multimedia Activities

February 2016
Updates in Chemotherapy-Induced Nausea and Vomiting: The Oncology Nurse and Oncology Nurse Practitioner’s Perspectives
Presenters: Ellen A. Neylon, MSN, FNP-BC, RN, CCRP, OCN, Erin L. Butzen, RN, BSN, OCN, Jennifer L. Converse, RN, BSN, OCN, Valarie S. Cook, RN, Keri A. Halsema, NP, Susan M. Koomen, NP, Emily A. Lichtenstein, RN, OCN, Kate Sherwood, RN, OCN

This activity has been designed to address the educational needs of advanced practice oncology nurse practitioners and oncology nurses who manage patients at risk of developing CINV. This activity will also be of benefit to other healthcare practitioners interested in the management of patients with CINV within the specialties of oncology/hematology, oncology nursing, and medical oncology.

Learning Objectives
Upon proper completion of this activity, participants should be better able to:

  • Evaluate the differences among antiemetic therapies used for the prevention and treatment of CINV.
  • Review clinical trial data for new and emerging antiemetic therapies for the prevention and treatment of CINV.
  • Discuss strategies to educate patients about CINV management and potential side effects of antiemetic therapies.

This activity is jointly provided by Global Education Group and Paradigm Medical Communications, LLC.

Commercial Support: This activity is supported by educational grants from Eisai Inc; Merck & Co., Inc, and TESARO, Inc.

Click here to begin this CME activity!

October 2015
Naloxone: The Universal Antidote for Opioid Overdose
Presenters: Perry G. Fine, MD, Jeffrey Gudin, MD, Michael J. Brennan, MD

Every day, approximately 113 people die from a drug overdose in the United Sates. According to the Centers for Disease Control (CDC), 74% of the 22,810 deaths attributed to drug overdoses in 2011 involved opioid pain relievers or prescription painkillers.

The purpose of this educational activity is to explain how healthcare providers can use screening and diagnostic tools to effectively identify high-risk patients. It will also review the appropriate treatments for opioid overdose. Lastly, this activity will examine barriers to access and review how healthcare providers can educate at-risk patients and their families about opioid safety, overdose reversal and how to administer naloxone at home.

Click here to begin this CME activity!

Commercial Support: This educational activity is provided by Dannemiller. Supported by Kaleo.